In vivo assessment of black seed oil single dose on prednisolone pharmacokinetics.
black seed interactions
herb–drug interactions
p-gp inhibition
prednisolone pharmacokinetics
Journal
The Journal of pharmacy and pharmacology
ISSN: 2042-7158
Titre abrégé: J Pharm Pharmacol
Pays: England
ID NLM: 0376363
Informations de publication
Date de publication:
18 Nov 2023
18 Nov 2023
Historique:
received:
28
08
2023
accepted:
07
11
2023
medline:
18
11
2023
pubmed:
18
11
2023
entrez:
18
11
2023
Statut:
aheadofprint
Résumé
To investigate the effect of blackseed oil (BSO) single dose on prednisolone pharmacokinetics via p-gp inhibition. Three groups of rats (n = 5) were orally administered the vehicle, verapamil (50 mg/kg) or BSO (5 ml/kg) 15 min prior to prednisolone (5 mg/kg) administration. Blood samples were collected over 24 h and quantified. Non-compartmental analysis was employed to calculate maximum plasma concentration (Cmax), area under the curve (AUC0-last), time to reach Cmax (Tmax), apparent clearance (CL/F), and half-life (t1/2). Statistical significance was considered at p<0.05. Prednisolone Cmax and AUC0-last decreased by 65% and 25% in the BSO group compared to the negative control (P < .0001, .0029, respectively) while they increased by 1.75-folds and 8-folds in verapamil group (P < .0001). Tmax was achieved at 0.16, 0.5, and 0.25 h in the negative control, verapamil, and BSO-treated groups, respectively. CL/F in the treatment group was 1.3-fold and 10-fold higher compared to the negative and positive control, respectively, whereas the t1/2 remained comparable. Administration of BSO decreased prednisolone Cmax and AUC0-last in rats indicating that there is a herb-drug interaction; however, p-gp inhibition cannot be concluded. Patients relying on folk medicine in chronic illnesses treatment might need to avoid combining BSO with prednisolone.
Identifiants
pubmed: 37978932
pii: 7428706
doi: 10.1093/jpp/rgad110
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Zarqa University
ID : RGP2/195/44
Organisme : King Khalid University
Informations de copyright
© The Author(s) 2023. Published by Oxford University Press on behalf of the Royal Pharmaceutical Society.